Beneficient (NASDAQ:BENF – Get Free Report)’s stock price traded down 7.2% during trading on Wednesday . The company traded as low as $0.61 and last traded at $0.64. 315,801 shares changed hands during trading, an increase of 52% from the average session volume of 208,310 shares. The stock had previously closed at $0.69.
Beneficient Trading Down 7.2 %
The business has a fifty day simple moving average of $0.70 and a 200 day simple moving average of $1.26.
Insider Buying and Selling at Beneficient
In related news, Director Peter T. Cangany, Jr. bought 75,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 19th. The shares were acquired at an average cost of $0.93 per share, with a total value of $69,750.00. Following the completion of the transaction, the director now owns 300,000 shares of the company’s stock, valued at approximately $279,000. The trade was a 33.33 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In the last 90 days, insiders have sold 20,186 shares of company stock worth $15,780. 13.69% of the stock is owned by insiders.
Institutional Investors Weigh In On Beneficient
About Beneficient
Beneficient, a technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States. It operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments.
Further Reading
- Five stocks we like better than Beneficient
- Retail Stocks Investing, Explained
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- What is Put Option Volume?
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.